Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from NanoVibronix ( (NAOV) ) is now available.
On February 14, 2025, NanoVibronix, Inc. completed a merger with ENvue Medical Holdings, Corp., resulting in ENvue becoming a wholly-owned subsidiary. The merger involved a complex share exchange and the issuance of Series X Non-Voting Convertible Preferred Stock, potentially allowing ENvue shareholders to own 85% of the combined company’s common stock if converted. The merger is part of a broader strategy, including stockholder proposals for stock conversions and a new incentive plan. This merger signifies a strategic shift for NanoVibronix, potentially reshaping its market position and operational dynamics, though it requires stockholder approval for certain aspects. New leadership appointments on the board indicate a focus on enhancing medical expertise and governance post-merger.
More about NanoVibronix
YTD Price Performance: -24.84%
Average Trading Volume: 3,435,279
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $2.86M
See more data about NAOV stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue